ClinicalTrials.govpublic full text
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
acute lymphocytic leukemia, acute myeloid leukemia, myelodysplastic syndrome, chronic myelogenous leukemia, leukemia, acute leukemia, relapsed acute leukemia, refractory acute leukemia, belinostat, bortezomib, velcade, pxd-101
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1009899
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.